CysLT1R antagonists block early P2Y6 receptor-dependent signaling that prevents type 2 allergic sensitization

Nagai, J; Lin, JR; Balestrieri, B; Fanning, L; Kyin, T; Cirka, H; Brennan, P; Boyce, J

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021; 147 (2): AB154